Lupus Logo

 
 


Submit Your Words of Appreciation

Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) recently announced positive top-line data from a 52-week clinical study of BENLYSTA™ as a potential new treatment for lupus. If results from a longer-term study due this fall also are positive, and the U.S Food and Drug Administration ultimately approves the medication, BENLYSTA could become the first new treatment for lupus in more than 50 years, and the first treatment ever developed specifically for lupus since the disease was first described by physicians more than a century ago.

The on-going efforts of many people are required to develop and test BENLYSTA. They included:

  • Researchers at HGS who spent years studying the immune system and discovered the B-lymphocyte stimulator, or BLyS®, a naturally occurring protein that is elevated in lupus and other autoimmune diseases.
  • Company officials at HGS and GSK for putting forth their pioneering effort but also their perseverance and fight to make this happen.
  • Physicians at clinical sites who served as study investigators administering the experimental drug and evaluating the patients' responses.
  • People with lupus who courageously volunteered to participate in the study and fulfilled all of the requirements for the year-long study.

Share your thoughts with those who are working to develop a new treatment for lupus. The LFA will publish several of the submitted stories on its website and in other publications.

In the space below, please share your thoughts with those who played a role in developing BENLYSTA paving the way to a possible new therapy for the millions of people around the world who are living with lupus.

General Rules

  • You must be 18 years or older. (Parents may submit their child’s story.)
  • You must be the author of your own story (it’s ok to have help with writing it but the story must be about you, not someone else).
  • Write clearly and concisely for a general audience. Use short sentences and common words.
  • Be brief. Your story should be less than 500 words (about one half of a standard size page).
  • Understand that LFA can not use every story that is submitted. However, LFA may be able to use your story for other purposes.
  • By submitting your story, you agree to these rules and the conditions and provisions contained in the author's release.
 
Your Contact Information: (* required fields)
Email Address:
   *
Prefix:
  
First Name:
  *
Last Name:
  *
Suffix:
   (e.g. M.D., R.N., Jr.)
Street Address:
 
City:
   *
State:
  *
Zip Code:
 
County or Parish:
   (U.S. residents only)
Country:
  
Home Telephone:
  
Work Telephone
  

Mobile Telephone

 
Age
   (You must be 18 or older)
   
Release:
  * I have read the rules and author's release and accept all terms and conditions. By checking this box, I authorize the LFA to release my personal information. Authorization will remain in effect until I notify LFA otherwise. Withdrawal of authorization is not retroactive.
 
Your Story:
 
 
 

 

 

 
© Lupus Foundation of America, Inc. All Rights Reserved. No part of this website may be reproduced without written permission.